Cited by 61Chromosomal and Genetic VariationsCancer-related molecular mechanisms researchTelomeres, Telomerase, and Senescence

Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer.

Open access
Rajurkar, Mihir, Parikh, Aparna R., Solovyov, Alexander, You, Eunae, Kulkarni, Anupriya S., Chu, Chong, Xu, Katherine H., Jaicks, Christopher +41 more·2022·Cancer Discovery

Published version of a preprint

Abstract

Altered RNA expression of repetitive sequences and retrotransposition are frequently seen in colorectal cancer, implicating a functional importance of repeat activity in cancer progression. We show the nucleoside reverse transcriptase inhibitor 3TC targets activities of these repeat elements in colorectal cancer preclinical models with a preferential effect in p53-mutant cell lines linked with direct binding of p53 to repeat elements. We translate these findings to a human phase II trial of single-agent 3TC treatment in metastatic colorectal cancer with demonstration of clinical benefit in 9 of 32 patients. Analysis of 3TC effects on colorectal cancer tumorspheres demonstrates accumulation of immunogenic RNA:DNA hybrids linked with induction of interferon response genes and DNA damage response. Epigenetic and DNA-damaging agents induce repeat RNAs and have enhanced cytotoxicity with 3TC. These findings identify a vulnerability in colorectal cancer by targeting the viral mimicry of repeat elements. Significance: Colorectal cancers express abundant repeat elements that have a viral-like life cycle that can be therapeutically targeted with nucleoside reverse transcriptase inhibitors (NRTI) commonly used for viral diseases. NRTIs induce DNA damage and interferon response that provide a new anticancer therapeutic strategy. This article is highlighted in the In This Issue feature, p. 1397

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-21-1117

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Noncoding hSATII RNA is highly expressed in most cancer cells and tissues.

    “Previous reports demonstrated that noncoding hSATII RNA is highly expressed in most cancer cells and tissues (27–32).”

    From Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment (2023) · cites this paper as [32]

    The Results section (“P53 is a Direct Repressor of Repeat RNA Expression”; page unavailable) reports higher HSATII expression in P53-mutant colorectal cancer cell lines and says satellite repeats are highly expressed in a broad set of cancers. The Results section on DNA damage also reports HSATII RNA in colorectal tumors, particularly after cytotoxic therapy. These passages support cancer-associated expression, but not the claim that HSATII is highly expressed in most cancer cells and tissues. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 60

  1. [1]Probst AV, Okamoto I, Casanova M, El Marjou F, Le Baccon P, Almouzni G. A strand-specific burst in transcription of pericentric satellites is required for chromocenter formation and early mouse development. Dev Cell 2010; 19(4): 625– 38 doi 10.1016/j.devcel.2010.09.002. 20951352 · DOI
  2. [2]Kano H, Godoy I, Courtney C, Vetter MR, Gerton GL, Ostertag EM, L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev 2009; 23(11): 1303– 12 doi 23/11/1303 [pii] 10.1101/gad.1803909. 19487571 PMC2701581 · DOI
  3. [3]Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ, Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 2011; 331(6017): 593– 6 doi science.1200801 [pii] 10.1126/science.1200801. 21233348 PMC3701432 · DOI · Paper page
  4. [5]Zapatka M, Borozan I, Brewer DS, Iskar M, Grundhoff A, Alawi M, The landscape of viral associations in human cancers. Nature genetics 2020; 52(3): 320– 30 doi 10.1038/s41588-019-0558-9. 32025001 PMC8076016 · DOI
  5. [6]Desai N, Sajed D, Arora KS, Solovyov A, Rajurkar M, Bledsoe JR, Diverse repetitive element RNA expression defines epigenetic and immunologic features of colon cancer. JCI Insight 2017; 2(3): e91078 doi 10.1172/jci.insight.91078. 28194445 PMC5291727 · DOI
  6. [7]Leonova KI, Brodsky L, Lipchick B, Pal M, Novototskaya L, Chenchik AA, p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs. Proc Natl Acad Sci U S A 2013; 110(1): E89– 98 doi 10.1073/pnas.1216922110. 23236145 PMC3538199 · DOI
  7. [8]Roulois D, Loo Yau H, Singhania R, Wang Y, Danesh A, Shen SY, DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts. Cell 2015; 162(5): 961– 73 doi 10.1016/j.cell.2015.07.056. 26317465 PMC4843502 · DOI · Paper page
  8. [9]Guler GD, Tindell CA, Pitti R, Wilson C, Nichols K, KaiWai Cheung T, Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure. Cancer cell 2017; 32(2): 221– 37 e13 doi 28781121
  9. [11]Sheng W, LaFleur MW, Nguyen TH, Chen S, Chakravarthy A, Conway JR, LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade. Cell 2018; 174(3): 549– 63 e19 doi 10.1016/j.cell.2018.05.052. 29937226 PMC6063761 · DOI · Paper page
  10. [13]Tanne A, Muniz LR, Puzio-Kuter A, Leonova KI, Gudkov AV, Ting DT, Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells. Proc Natl Acad Sci U S A 2015; 112(49): 15154– 9 doi 10.1073/pnas.1517584112. 26575629 PMC4679042 · DOI · Paper page
  11. [14]Lee E, Iskow R, Yang L, Gokcumen O, Haseley P, Luquette LJ 3rd, Landscape of somatic retrotransposition in human cancers. Science 2012; 337(6097): 967– 71 doi science.1222077 [pii] 10.1126/science.1222077. 22745252 PMC3656569 · DOI · Paper page
  12. [15]Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, Zamora J, Supek F, Demeulemeester J, Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nature genetics 2020; 52(3): 306– 19 doi 10.1038/s41588-019-0562-0. 32024998 PMC7058536 · DOI · Paper page
  13. [16]Bersani F, Lee E, Kharchenko PV, Xu AW, Liu M, Xega K, Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer. Proc Natl Acad Sci U S A 2015; 112(49): 15148– 53 doi 10.1073/pnas.1518008112. 26575630 PMC4679016 · DOI · Paper page
  14. [18]Kwon J, Bakhoum SF. The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer. Cancer discovery 2020; 10(1): 26– 39 doi 10.1158/2159-8290.CD-19-0761. 31852718 PMC7151642 · DOI · Paper page
  15. [20]Contreras-Galindo RA, Dube D, Fujinaga K, Kaplan MH, Markovitz DM. Susceptibility of Human Endogenous Retrovirus Type-K to Reverse Transcriptase Inhibitors. Journal of virology 2017; 91(23): e01309– 17 doi 10.1128/JVI.01309-17. PMC5686744 28931682 · DOI
  16. [23]Simon M, Van Meter M, Ablaeva J, Ke Z, Gonzalez RS, Taguchi T, LINE1 Derepression in Aged Wild-Type and SIRT6-Deficient Mice Drives Inflammation. Cell Metabolism 2019; 29(4): 871– 85. e5 doi 10.1016/j.cmet.2019.02.014. 30853213 PMC6449196 · DOI · Paper page
  17. [24]Wylie A, Jones AE, D’Brot A, Lu WJ, Kurtz P, Moran JV, p53 genes function to restrain mobile elements. Genes Dev 2016; 30(1): 64– 77 doi 10.1101/gad.266098.115. 26701264 PMC4701979 · DOI
  18. [25]Jung H, Choi JK, Lee EA. Immune signatures correlate with L1 retrotransposition in gastrointestinal cancers. Genome Res 2018; 28(8): 1136– 46 doi 10.1101/gr.231837.117. 29970450 PMC6071633 · DOI
  19. [26]Solovyov A, Vabret N, Arora KS, Snyder A, Funt SA, Bajorin DF, Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes. Cell reports 2018; 23(2): 512– 21 doi 10.1016/j.celrep.2018.03.042. 29642008 PMC6016853 · DOI
  20. [27]Zhu J, Sammons MA, Donahue G, Dou Z, Vedadi M, Getlik M, Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth. Nature 2015; 525(7568): 206– 11 doi 10.1038/nature15251. 26331536 PMC4568559 · DOI · Paper page
  21. [28]Levine AJ, Ting DT, Greenbaum BD. P53 and the defenses against genome instability caused by transposons and repetitive elements. BioEssays: news and reviews in molecular, cellular and developmental biology 2016; 38(6): 508– 13 doi 10.1002/bies.201600031. 27172878 PMC5031199 · DOI
  22. [29]Chu C, Borges-Monroy R, Viswanadham VV, Lee S, Li H, Lee EA, Comprehensive identification of transposable element insertions using multiple sequencing technologies. Nature communications 2021; 12(1): 3836 doi 10.1038/s41467-021-24041-8. PMC8219666 34158502 · DOI
  23. [30]Cohen L, Cui N, Cai Y, Garden PM, Li X, Weitz DA, Single Molecule Protein Detection with Attomolar Sensitivity Using Droplet Digital Enzyme-Linked Immunosorbent Assay. ACS Nano 2020; 14(8): 9491– 501 doi 10.1021/acsnano.0c02378. 32589401 · DOI
  24. [31]Mankan AK, Schmidt T, Chauhan D, Goldeck M, Höning K, Gaidt M, Cytosolic RNA:DNA hybrids activate the cGAS-STING axis. Embo j 2014; 33(24): 2937– 46 doi 10.15252/embj.201488726. 25425575 PMC4282641 · DOI
  25. [32]Boye K, Jacob H, Frikstad KA, Nesland JM, Maelandsmo GM, Dahl O, Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy. Cancer Med 2016; 5(8): 1840– 9 doi 10.1002/cam4.766. 27273130 PMC4971912 · DOI
  26. [33]Boye K, Nesland JM, Sandstad B, Haugland Haugen M, Mælandsmo GM, Flatmark K. EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer. Br J Cancer 2012; 107(4): 667– 74 doi 10.1038/bjc.2012.293. 22782346 PMC3419949 · DOI
  27. [34]Kang YG, Jung CK, Lee A, Kang WK, Oh ST, Kang CS. Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer. J Surg Oncol 2012; 105(2): 119– 24 doi 10.1002/jso.22070. 21837681 · DOI
  28. [35]Sack U, Walther W, Scudiero D, Selby M, Aumann J, Lemos C, S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells. Mol Biol Cell 2011; 22(18): 3344– 54 doi 10.1091/mbc.E10-09-0739. 21795396 PMC3172260 · DOI
  29. [36]Wang H, Shi J, Luo Y, Liao Q, Niu Y, Zhang F, LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression. Clinical cancer research: an official journal of the American Association for Cancer Research 2014; 20(22): 5835– 47 doi 25252758
  30. [37]Zuo Z, Zhang P, Lin F, Shang W, Bi R, Lu F, Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation. J Cell Mol Med 2018; 22(4): 2430– 41 doi 10.1111/jcmm.13541. 29383839 PMC5867135 · DOI
  31. [38]Watanabe H, Ishibashi K, Mano H, Kitamoto S, Sato N, Hoshiba K, Mutant p53-Expressing Cells Undergo Necroptosis via Cell Competition with the Neighboring Normal Epithelial Cells. Cell reports 2018; 23(13): 3721– 9 doi 10.1016/j.celrep.2018.05.081. 29949757 · DOI
  32. [39]Zhu Q, Hoong N, Aslanian A, Hara T, Benner C, Heinz S, Heterochromatin-Encoded Satellite RNAs Induce Breast Cancer. Molecular cell 2018; 70(5): 842– 53 e7 doi 10.1016/j.molcel.2018.04.023. 29861157 PMC6545586 · DOI
  33. [40]Zhu Q, Pao GM, Huynh AM, Suh H, Tonnu N, Nederlof PM, BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 2011; 477(7363): 179– 84 doi nature10371 [pii] 10.1038/nature10371 [doi]. 21901007 PMC3240576 · DOI
  34. [41]Kishikawa T, Otsuka M, Yoshikawa T, Ohno M, Ijichi H, Koike K. Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1. Nature communications 2016; 7(13006): 1– 12 doi 10.1038/ncomms13006. PMC5052683 27667193 · DOI
  35. [42]Ardeljan D, Steranka JP, Liu C, Li Z, Taylor MS, Payer LM, Cell fitness screens reveal a conflict between LINE-1 retrotransposition and DNA replication. Nat Struct Mol Biol 2020; 27(2): 168– 78 doi 10.1038/s41594-020-0372-1. 32042151 PMC7080318 · DOI · Paper page
  36. [43]Mita P, Sun X, Fenyo D, Kahler DJ, Li D, Agmon N, BRCA1 and S phase DNA repair pathways restrict LINE-1 retrotransposition in human cells. Nat Struct Mol Biol 2020; 27(2): 179– 91 doi 10.1038/s41594-020-0374-z. 32042152 PMC7082080 · DOI · Paper page
  37. [44]Taylor MS, Altukhov I, Molloy KR, Mita P, Jiang H, Adney EM, Dissection of affinity captured LINE-1 macromolecular complexes. Elife 2018; 7 doi 10.7554/eLife.30094. PMC5821459 29309035 · DOI
  38. [45]Stavrou S, Aguilera AN, Blouch K, Ross SR. DDX41 Recognizes RNA/DNA Retroviral Reverse Transcripts and Is Critical for In Vivo Control of Murine Leukemia Virus Infection. mBio 2018; 9(3): e00923– 18 doi 10.1128/mBio.00923-18. 29871919 PMC5989071 · DOI
  39. [46]Parikh AR, Szabolcs A, Allen JN, Clark JW, Wo JY, Raabe M, Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial. Nature Cancer 2021; 2(11): 1124– 35 doi 10.1038/s43018-021-00269-7. 35122060 PMC8809884 · DOI
  40. [48]Panda A, de Cubas AA, Stein M, Riedlinger G, Kra J, Mayer T, Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma. JCI Insight 2018; 3(16) doi 10.1172/jci.insight.121522. PMC6141170 30135306 · DOI · Paper page
  41. [49]Hughes SM, Levy CN, Calienes FL, Stekler JD, Pandey U, Vojtech L, Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection. Cell Rep Med 2020; 1(6): 100096 doi 10.1016/j.xcrm.2020.100096. 33015651 PMC7511692 · DOI
  42. [50]Coghill AE, Engels EA, Schymura MJ, Mahale P, Shiels MS. Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States. J Natl Cancer Inst 2018; 110(9): 959– 66 doi 10.1093/jnci/djy010. 29529223 PMC6136931 · DOI
  43. [51]Ho DD. Time to hit HIV, early and hard. N Engl J Med 1995; 333(7): 450– 1 doi 10.1056/nejm199508173330710. 7616996 · DOI
  44. [52]Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996; 271(5255): 1582– 6 doi 10.1126/science.271.5255.1582. 8599114 · DOI
  45. [53]Zhou X, Singh M, Sanz Santos G, Guerlavais V, Carvajal LA, Aivado M, Pharmacological activation of p53 triggers viral mimicry response thereby abolishing tumor immune evasion and promoting anti-tumor immunity. Cancer discovery 2021 doi 10.1158/2159-8290.CD-20-1741. PMC9414294 34230007 · DOI · Paper page
  46. [54]Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2012; 29(1): 15– 21 doi 10.1093/bioinformatics/bts635. 23104886 PMC3530905 · DOI · Paper page
  47. [55]Liao Y, Smyth GK, Shi W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res 2013; 41(10): e108 doi 10.1093/nar/gkt214. 23558742 PMC3664803 · DOI · Paper page
  48. [56]Frankish A, Diekhans M, Ferreira AM, Johnson R, Jungreis I, Loveland J, GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res 2019; 47(D1): D766– D73 doi 10.1093/nar/gky955. 30357393 PMC6323946 · DOI
  49. [57]Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010; 26(1): 139– 40 doi 10.1093/bioinformatics/btp616. 19910308 PMC2796818 · DOI · Paper page
  50. [58]Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 2010; 11(3): R25 doi 10.1186/gb-2010-11-3-r25. 20196867 PMC2864565 · DOI · Paper page
  51. [59]Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014; 15(12): 550 doi 10.1186/s13059-014-0550-8. 25516281 PMC4302049 · DOI · Paper page
  52. [60]Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A. Fast gene set enrichment analysis. bioRxiv 2021: 060012 doi 10.1101/060012. · DOI
  53. [61]Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25(14): 1754– 60 doi 10.1093/bioinformatics/btp324. 19451168 PMC2705234 · DOI · Paper page
  54. [63]Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25(16): 2078– 9 doi 10.1093/bioinformatics/btp352. 19505943 PMC2723002 · DOI · Paper page
  55. [64]Lee S, Lee S, Ouellette S, Park WY, Lee EA, Park PJ. NGSCheckMate: software for validating sample identity in next-generation sequencing studies within and across data types. Nucleic Acids Res 2017; 45(11): e103 doi 10.1093/nar/gkx193. 28369524 PMC5499645 · DOI
  56. [66]Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature genetics 2003; 34(3): 267– 73 doi 10.1038/ng1180. 12808457 · DOI · Paper page
  57. [67]Shah PP, Donahue G, Otte GL, Capell BC, Nelson DM, Cao K, Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape. Genes Dev 2013; 27(16): 1787– 99 doi 10.1101/gad.223834.113. 23934658 PMC3759695 · DOI · Paper page
  58. [68]Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9(4): 357– 9 doi 10.1038/nmeth.1923. 22388286 PMC3322381 · DOI · Paper page
  59. [69]Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Model-based analysis of ChIP-Seq (MACS). Genome Biol 2008; 9(9): R137 doi 10.1186/gb-2008-9-9-r137. 18798982 PMC2592715 · DOI · Paper page
  60. [70]Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010; 26(6): 841– 2 doi 10.1093/bioinformatics/btq033. 20110278 PMC2832824 · DOI · Paper page

Cited by

Sorted by citations

Authors
Rajurkar, M., Parikh, A. R., Solovyov, A., You, E., Kulkarni, A. S., Chu, C., Xu, K. H., Jaicks, C., Taylor, M. S., Wu, C., Alexander, K. A., Good, C. R., Szabolcs, A., Gerstberger, S., Tran, A. V., Xu, N., Ebright, R. Y., Van Seventer, E. E., Vo, K. D., Tai, E. C., Lu, C., Joseph-Chazan, J., Raabe, M. J., Nieman, L. T., Desai, N., Arora, K. S., Ligorio, M., Thapar, V., Cohen, L., Garden, P. M., Senussi, Y., Zheng, H., Allen, J. N., Blaszkowsky, L. S., Clark, J. W., Goyal, L., Wo, J. Y., Ryan, D. P., Corcoran, R. B., Deshpande, V., Rivera, M. N., Aryee, M. J., Hong, T. S., Berger, S. L., Walt, D. R., Burns, K. H., Park, P. J., Greenbaum, B. D., & Ting, D. T.
Affiliations
  • Harvard University (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • Brigham and Women's Hospital (US)
  • University of Pennsylvania (US)
  • 1Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.
  • Massachusetts General Hospital (US)
Corresponding author
  • Greenbaum, Benjamin D.
  • Ting, David T.
Venue
Cancer Discovery
Published
2022-03-23
Volume
12
Issue
6
Pages
1462-1481
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W4225729206
Cited by
61
References
10
Citations by year
2026: 12 · 2025: 13 · 2024: 14 · 2023: 17 · 2022: 5
FWCI
6.75
Type
journal article
Language
en
Open access
Locations
  • Cancer Discovery (publishedVersion)
  • Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
Funders
  • NIH (R01CA240924, U01CA228963, R01GM130680, R01CA240816, T32GM007753, 1F30CA232407-01)
  • Gateway for Cancer Research (G-17-1000)
  • National Science Foundation (PHY-1549535)
  • Burroughs Wellcome Fund (1010968.01)
  • V Foundation for Cancer Research (D2015-034)
  • SU2C (AACR-PS-17)
  • SU2C-Lustgarten Foundation (2015-002)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Chromosomal and Genetic Variations
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
Keywords
colorectal cancer, nucleoside reverse transcriptase inhibitors, lamivudine, repetitive elements, retrotransposition, TP53 mutation, RNA-DNA hybrids, interferon response, DNA damage response, tumor spheres, metastatic colorectal cancer, monotherapy, epigenetic agents, viral mimicry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review